The most recent items are listed first

• Response biomedical receives fda 510 k clearance of rapid influenza a b test
• Ramp flu a demonstrated to be more sensitive than other rapid tests
• Only ramp meets new standards for rapid anthrax detection
• Response biomedical emerges from creditor protection